The small peptide is screeted by the cells within the small and large intestines. IT has low levels in the blood before eating, but rises rapidly after consuming meals. Injections of the peptide can curb appetites in humans and animals. Low average levels of the peptide are associated with obesity. This suggests that PPY (3-36) acts as a appetite-suppressing stimuli to the hypothalamus.